Phase I study of Gleevec (imatinib mesylate, formerly known as STI1571) and gemcitabine in patient with refractory solid-tumor malignancy
Latest Information Update: 19 Jan 2006
At a glance
- Drugs Imatinib (Primary) ; Gemcitabine
- Indications Solid tumours
- Focus Adverse reactions
- 19 Jan 2006 New trial record.